Condition

Chemotherapy-induced Nausea and Vomiting

ClinicalTrials.gov condition label

Clinical trials11
Recruiting0
Common interventions22
Lead sponsors shown10

Clinical trials

11 shown
Effect of Foot Reflexology On Chemotherapy Induced Nausea and Vomiting in Breast Cancer PatientsNCT07322393 · 2026-06-01
NOT_YET_RECRUITING
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast CancerNCT05841849 · 2023-07-01
NOT_YET_RECRUITING
Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer ChemotherapyNCT03948477 · 2019-06-10
COMPLETED
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung CancerNCT03571126 · 2019-05-09
UNKNOWN
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast CancerNCT03403712 · 2018-03-16
COMPLETED
Effect of tDCS of the Motor Cortex on Chemotherapy Induced Nausia and VomitingNCT03405324 · 2018-01-01
UNKNOWN
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and VomitingNCT03232541 · 2017-09-01
COMPLETED
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by CisplatinNCT04201769 · 2016-11-25
UNKNOWN
NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast CancerNCT03862144 · 2016-05-12
COMPLETED
Effect of Yoga in Reducing Chemotherapy Induced Nausea and VomitingNCT01387841 · 2010-05-01
COMPLETED
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsNCT00086762 · 2004-06-01
COMPLETED

Trial status mix

COMPLETED6
UNKNOWN3
NOT_YET_RECRUITING2

Phase mix

NA4
PHASE23
PHASE32
PHASE42

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.